Clinical Trial Update: Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase III trial comparing SHR-8068 plus Adebrelimab and chemotherapy versus Tislelizumab plus chemotherapy for locally advanced or metastatic non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• SHR-8068
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Advanced or Metastatic Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING